Pausing the treatment of vulnerable people on immunosuppressants doubles their antibody response to the coronavirus booster vaccination, a new study has suggested.
Researchers looked at the effect of interrupting treatment with methotrexate – prescribed for inflammatory conditions such as rheumatoid arthritis and skin conditions such as psoriasis – for two weeks after the jab.
